<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4263</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.132309</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Synthesis, Spectral Characterization of Azithromycin with Transition Metals and a Molecular Approach for Azithromycin with Zinc for COVID-19&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kolkaila</surname><given-names>Sherif A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ali</surname><given-names>Alaa E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Elasala</surname><given-names>Gehan S.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>1</day><month>12</month><year>2021</year></pub-date><volume>3)</volume><issue/><fpage>53</fpage><lpage>59</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: The discovery of azithromycin (Figure 1) as a type of macrolide was very important in the 20th century which was presented as an example of medicinal chemistry and drug design. Recently, azithromycin has a special and interesting profile in this research on pharmacotherapy for COVID-19. Aim and Objective: Synthesis, spectral characterization and thermal analysis of azithromycin complexes with transition metals (Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and Hg(II)) were discussed. Method: Azithromycin act as a bidentate ligand with the formation of 1:2 (M: L). measurement of magnetism and spectral data shows octahedral structures for all complexes. Result: All of them have Oh geometry and these results are confirmed by Nujol and ESR spectra. Azithromycin act as a bidentate ligand through N (CH3)2 group of dopamine and a hydroxyl group. Also have different sites available for coordination that carries more electronegative charges and the computational study confirms these results. Conclusion: Hyper chemistry program confirmed the binding sites of azithromycin. Azithromycin complexes have higher activity than commercial azithromycin for some strains with the remarkable effect of Zn-azithromycin complex. A molecular approach for COVID-19 was studied.&#13;
</p></abstract><kwd-group><kwd> Macrolide complexes</kwd><kwd> Azithromycin Complexes</kwd><kwd> Biological activity</kwd><kwd> COVID-19</kwd></kwd-group></article-meta></front></article>
